Roth Capital Starts Cell Therapeutics (CTIC) at Buy

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/12/2026

1. SKHY
2. SPY
3. USO
4. DAL
5. PEP
6. META
7. SKHYV
8. ALP
9. NVDA
10. NRIX

October 26, 2012 8:27 AM EDT
Get Alerts CTIC Hot Sheet
Price: $9.09 --0%

Rating Summary:
    10 Buy, 6 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 14 | Down: 11 | New: 17
Join SI Premium – FREE
Roth Capital initiates coverage on Cell Therapeutics (NASDAQ: CTIC) with a Buy. PT $4.00.

For an analyst ratings summary and ratings history on Cell Therapeutics click here. For more ratings news on Cell Therapeutics click here.

Shares of Cell Therapeutics closed at $1.54 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Hot New Coverage, New Coverage

Related Entities

Roth Capital